{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T07:33:43Z","timestamp":1764401623565},"reference-count":9,"publisher":"Elsevier BV","issue":"13","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.vaccine.2013.11.011","type":"journal-article","created":{"date-parts":[[2013,12,10]],"date-time":"2013-12-10T01:16:14Z","timestamp":1386638174000},"page":"1421-1422","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Trend of human rabies prophylaxis in developing countries: Toward optimal rabies immunization"],"prefix":"10.1016","volume":"32","author":[{"given":"Mary J.","family":"Warrell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2013.11.011_bib0005","doi-asserted-by":"crossref","first-page":"4079","DOI":"10.1016\/j.vaccine.2013.06.083","article-title":"Trend of human rabies prophylaxis in developing countries: toward optimal rabies immunization","volume":"31","author":"Permpalung","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.11.011_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tmaid.2011.12.005","article-title":"Current rabies vaccines and prophylaxis schedules: preventing rabies before and after exposure","volume":"10","author":"Warrell","year":"2012","journal-title":"Travel Med Infect Dis"},{"key":"10.1016\/j.vaccine.2013.11.011_bib0015","doi-asserted-by":"crossref","first-page":"e224","DOI":"10.1371\/journal.pntd.0000224","article-title":"A simplified 4-site economical intradermal post-exposure rabies vaccine regimen: a randomised controlled comparison with standard methods","volume":"2","author":"Warrell","year":"2008","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2013.11.011_bib0020","series-title":"World health organization expert consultation on rabies. First report. WHO technical report series 931","first-page":"71","year":"2005"},{"key":"10.1016\/j.vaccine.2013.11.011_bib0025","series-title":"Report of the WHO\/Bill and Melinda Gates Foundation Consultation on Human and Dog Rabies Prevention and Control","first-page":"21","year":"2009"},{"key":"10.1016\/j.vaccine.2013.11.011_bib0045","first-page":"15","article-title":"Immunogenicity and safety of three intradermal anti-rabies vaccination regimens using purified vero cell rabies vaccine","volume":"10","author":"Quiambao","year":"2008","journal-title":"Ass Prevention Control Rabies India J"},{"key":"10.1016\/j.vaccine.2013.11.011_bib0030","doi-asserted-by":"crossref","first-page":"e982","DOI":"10.1371\/journal.pntd.0000982","article-title":"Evaluation of cost-effective strategies for rabies post-exposure vaccination in low-income countries","volume":"5","author":"Hampson","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2013.11.011_bib0035","doi-asserted-by":"crossref","first-page":"4116","DOI":"10.1016\/j.vaccine.2006.02.036","article-title":"Rabies post-exposure prophylaxis vaccination with purified chick embryo cell vaccine (PCECV) and purified Vero cell rabies vaccine (PVRV) in a four-site intradermal schedule (4-0-2-0-1-1): an immunogenic, cost-effective and practical regimen","volume":"24","author":"Ambrozaitis","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.11.011_bib0040","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1128\/AEM.27.3.553-561.1974","article-title":"Antibody response to a human diploid cell rabies vaccine","volume":"27","author":"Cabasso","year":"1974","journal-title":"Appl Microbiol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13015284?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13015284?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,11]],"date-time":"2020-08-11T21:06:49Z","timestamp":1597180009000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X13015284"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":9,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S0264410X13015284"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.11.011","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trend of human rabies prophylaxis in developing countries: Toward optimal rabies immunization","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.11.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.06.083","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}